Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 9201.T
Valuation Bad
0%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Balanced
50%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio 0.58 1.39 1.38
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 15.43 3.28 2.84
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 3.79 2082.22 2006.26
Cash 4.59 1671.23 1597.92
Capex 17.56 -137.45 -166.74
Free Cash Flow 111.19 62.78 -29.72
Revenue -6.05 921.09 980.36
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin 39.26 0.68 0.49
Operating Margin -57.56 0.04 0.09
ROA -60.50 < 0.005 < 0.005
ROE -61.54 0.01 0.03
ROIC -67.76 < 0.005 0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 9201.T is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 9201.T is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 9201.T is permitted for members.